trial

Texting for Relapse Prevention

NCTId NCT02819349
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 40 (actual)
Sponsored by Center for Innovative Public Health Research
Primary completion 2019-04-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
40 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2018-03-12
Primary completion
2019-04-09
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Texting for Relapse Prevention (T4RP)

Sponsors

Center for Innovative Public Health ResearchLead Sponsor
Johns Hopkins UniversityCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

2
Michele Ybarra, PhDPrincipal Investigator
Bernadette Cullen, PhDPrincipal Investigator

Sites

1 total
Baltimore, United States

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2019-04-09
Status
COMPLETED
relationships
The graph out of here
drug
Texting for Relapse Prevention (T4RP)
drug
lead_sponsor
Center for Innovative Public Health Research
company
collaborator
Johns Hopkins University
company
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Michele Ybarra, PhD
person
Bernadette Cullen, PhD
person